SWHR Supports HELP Committee’s Califf Approval; Urges Confirmation by Senate
Washington, D.C., January 12, 2016 – The United States Senate Committee on Health, Education, Labor and Pensions (HELP) unanimously approved Dr. Robert Califf’s nomination to serve as U.S. Food and Drug Administration (FDA) Commissioner, moving the process to the full Senate for a final vote.
The Society for Women’s Health Research (SWHR®) strongly supports the HELP Committee’s approval and urges an immediate confirmation by the full Senate. SWHR, one of 50 organizations supporting Dr. Califf’s confirmation, believes he will provide strong leadership and direction to improve FDA’s drug approval process, while ensuring that safety and effectiveness are not compromised.
Dr. Califf, a distinguished cardiologist and medical researcher, was nominated to the post in September by President Barack Obama. Dr. Califf joined the FDA as deputy commissioner after serving as the vice chancellor of clinical and translational research at Duke University in Durham, NC, where he also was director of the Duke Translational Medicine Institute (DTMI). In addition, he was a professor of medicine in the Division of Cardiology at the Duke University Medical Center, and the founding director of the Duke Clinical Research Institute (DCRI).
“He is a widely respected leader in the field of clinical research and has the perspective and experience to lead the FDA during this critical juncture,” said Phyllis Greenberger, MSW, president and CEO of SWHR. “We thank the Senate HELP Committee for their quick approval and urge the full Senate to confirm him to the post. We look forward to working with him and the FDA to ensure that Americans have access to the latest medical treatments and that these treatments are safe and effective.”
###
About SWHR
The Society for Women’s Health Research (SWHR®), is a national non-profit based in Washington D.C. that is widely recognized as the thought-leader in promoting research on biological differences in disease. SWHR is dedicated to transforming women’s health through science, advocacy, and education. Founded in 1990 by a group of physicians, medical researchers and health advocates, SWHR aims to bring attention to the variety of diseases and conditions that disproportionately or predominately affect women. For more information, please visit www.swhrdev.wpengine.com. Follow us on Twitter at @SWHR.
Washington, D.C., January 12, 2016 – The United States Senate Committee on Health, Education, Labor and Pensions (HELP) unanimously approved Dr. Robert Califf’s nomination to serve as U.S. Food and Drug Administration (FDA) Commissioner, moving the process to the full Senate for a final vote.
The Society for Women’s Health Research (SWHR®) strongly supports the HELP Committee’s approval and urges an immediate confirmation by the full Senate. SWHR, one of 50 organizations supporting Dr. Califf’s confirmation, believes he will provide strong leadership and direction to improve FDA’s drug approval process, while ensuring that safety and effectiveness are not compromised.
Dr. Califf, a distinguished cardiologist and medical researcher, was nominated to the post in September by President Barack Obama. Dr. Califf joined the FDA as deputy commissioner after serving as the vice chancellor of clinical and translational research at Duke University in Durham, NC, where he also was director of the Duke Translational Medicine Institute (DTMI). In addition, he was a professor of medicine in the Division of Cardiology at the Duke University Medical Center, and the founding director of the Duke Clinical Research Institute (DCRI).
“He is a widely respected leader in the field of clinical research and has the perspective and experience to lead the FDA during this critical juncture,” said Phyllis Greenberger, MSW, president and CEO of SWHR. “We thank the Senate HELP Committee for their quick approval and urge the full Senate to confirm him to the post. We look forward to working with him and the FDA to ensure that Americans have access to the latest medical treatments and that these treatments are safe and effective.”
###
About SWHR
The Society for Women’s Health Research (SWHR®), is a national non-profit based in Washington D.C. that is widely recognized as the thought-leader in promoting research on biological differences in disease. SWHR is dedicated to transforming women’s health through science, advocacy, and education. Founded in 1990 by a group of physicians, medical researchers and health advocates, SWHR aims to bring attention to the variety of diseases and conditions that disproportionately or predominately affect women. For more information, please visit www.swhrdev.wpengine.com. Follow us on Twitter at @SWHR.